LOADING
Comparing Merck & Company (MRK) and Qualcomm Inc (QCOM) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | QCOM |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $307.2B | $155.0B |
| P/E Ratio | 36.7 | 16.9 |
| Forward P/E | 48.3 | 14.0 |
| PEG Ratio | 12.06 | 0.63 |
| EPS | $3.55 | $8.75 |
| Revenue Growth (YoY) | 4.9% | -4.0% |
| Profit Margin | 13.6% | 21.0% |
| Return on Equity | 18.9% | 33.8% |
| Dividend Yield | 2.53% | 2.37% |
| Beta | 0.20 | 1.64 |
| 52-Week High | $135.05 | $258.96 |
| 52-Week Low | $75.81 | $121.54 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. Qualcomm Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. Qualcomm Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.